India · Delayed Price · Currency is INR Alivus Life Sciences Statistics
Total Valuation
BOM:543322 has a market cap or net worth of INR 142.38 billion. The enterprise value is 135.12 billion.
| Market Cap | 142.38B |
| Enterprise Value | 135.12B |
Important Dates
The last earnings date was Thursday, July 30, 2026.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | Sep 1, 2025 |
Share Statistics
| Current Share Class | 122.74M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 10.95% |
| Float | 30.84M |
Valuation Ratios
The trailing PE ratio is 23.61 and the forward PE ratio is 18.42.
| PE Ratio | 23.61 |
| Forward PE | 18.42 |
| PS Ratio | 5.50 |
| PB Ratio | 4.27 |
| P/TBV Ratio | 4.31 |
| P/FCF Ratio | 55.11 |
| P/OCF Ratio | 25.18 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.12, with an EV/FCF ratio of 52.30.
| EV / Earnings | 22.41 |
| EV / Sales | 5.22 |
| EV / EBITDA | 16.12 |
| EV / EBIT | 17.83 |
| EV / FCF | 52.30 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.07 |
| Debt / FCF | 0.22 |
| Interest Coverage | 139.61 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 21.90% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 11.76M |
| Profits Per Employee | 2.74M |
| Employee Count | 2,203 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:543322 has paid 1.98 billion in taxes.
| Income Tax | 1.98B |
| Effective Tax Rate | 24.67% |
Stock Price Statistics
The stock price has increased by +4.33% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +4.33% |
| 50-Day Moving Average | 1,097.03 |
| 200-Day Moving Average | 982.63 |
| Relative Strength Index (RSI) | 57.53 |
| Average Volume (20 Days) | 11,031 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:543322 had revenue of INR 25.90 billion and earned 6.03 billion in profits. Earnings per share was 49.03.
| Revenue | 25.90B |
| Gross Profit | 15.39B |
| Operating Income | 7.58B |
| Pretax Income | 8.01B |
| Net Income | 6.03B |
| EBITDA | 8.38B |
| EBIT | 7.58B |
| Earnings Per Share (EPS) | 49.03 |
Balance Sheet
The company has 7.83 billion in cash and 567.71 million in debt, with a net cash position of 7.26 billion.
| Cash & Cash Equivalents | 7.83B |
| Total Debt | 567.71M |
| Net Cash | 7.26B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 33.32B |
| Book Value Per Share | 271.02 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 5.65 billion and capital expenditures -3.07 billion, giving a free cash flow of 2.58 billion.
| Operating Cash Flow | 5.65B |
| Capital Expenditures | -3.07B |
| Depreciation & Amortization | 804.53M |
| Net Borrowing | -80.21M |
| Free Cash Flow | 2.58B |
| FCF Per Share | n/a |
Margins
Gross margin is 59.42%, with operating and profit margins of 29.25% and 23.28%.
| Gross Margin | 59.42% |
| Operating Margin | 29.25% |
| Pretax Margin | 30.90% |
| Profit Margin | 23.28% |
| EBITDA Margin | 32.36% |
| EBIT Margin | 29.25% |
| FCF Margin | 10.12% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.46%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 0.46% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.04% |
| Shareholder Yield | 0.42% |
| Earnings Yield | 4.24% |
| FCF Yield | 1.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BOM:543322 is 1,335.00, which is 13.65% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 1,335.00 |
| Price Target Difference | 13.65% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 10.64% |
| EPS Growth Forecast (3Y) | 10.88% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |